These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
560 related articles for article (PubMed ID: 22023211)
1. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation. Aggarwal G; Dhawan S; HariKumar SL Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211 [TBL] [Abstract][Full Text] [Related]
2. Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine. Aggarwal G; Dhawan S; Harikumar SL Pharm Dev Technol; 2013; 18(4):916-25. PubMed ID: 21913873 [TBL] [Abstract][Full Text] [Related]
3. Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone. Aggarwal G; Dhawan S; Hari Kumar SL Drug Dev Ind Pharm; 2013 Jan; 39(1):39-50. PubMed ID: 22335586 [TBL] [Abstract][Full Text] [Related]
4. Penetration effect of ostrich oil as a promising vehicle on transdermal delivery of sinomenine. Liu X; Chen T; Liu X; Chen Y; Wang L J Oleo Sci; 2013; 62(9):657-64. PubMed ID: 24005010 [TBL] [Abstract][Full Text] [Related]
5. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
6. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system. Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679 [TBL] [Abstract][Full Text] [Related]
7. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride. Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528 [TBL] [Abstract][Full Text] [Related]
8. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine. Mittal A; Sara US; Ali A; Mohammed A Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699 [TBL] [Abstract][Full Text] [Related]
9. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS. Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer. Liu C; Farah N; Weng W; Jiao B; Shen M; Fang L Eur J Pharm Sci; 2019 Oct; 138():105009. PubMed ID: 31306781 [TBL] [Abstract][Full Text] [Related]
11. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation. Cui H; Quan P; Zhou Z; Fang L Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038 [TBL] [Abstract][Full Text] [Related]
12. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin. Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334 [TBL] [Abstract][Full Text] [Related]
14. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization. Rastogi V; Yadav P; Husain A; Verma A Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation. Yang Z; Teng Y; Wang H; Hou H Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076 [TBL] [Abstract][Full Text] [Related]
16. Development of essential oils as skin permeation enhancers: penetration enhancement effect and mechanism of action. Jiang Q; Wu Y; Zhang H; Liu P; Yao J; Yao P; Chen J; Duan J Pharm Biol; 2017 Dec; 55(1):1592-1600. PubMed ID: 28399694 [TBL] [Abstract][Full Text] [Related]
17. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats. Baviskar DT; Parik VB; Jain DJ PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560 [TBL] [Abstract][Full Text] [Related]
18. Fabrication, evaluation, and enhanced penetration of vinyl and cellulose-engineered transdermal patch of nifedipine using essential oil as penetration enhancer. Das S; Das S; Bahadur S; Mukherjee M; Nandi G; Manna S J Biomater Sci Polym Ed; 2024 Jun; 35(9):1400-1420. PubMed ID: 38502545 [TBL] [Abstract][Full Text] [Related]
19. Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation. Liu C; Fang L AAPS PharmSciTech; 2015 Dec; 16(6):1245-53. PubMed ID: 25771739 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation. Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]